Feminai develops a smart, wearable, disposable patch that enables women to conduct self-tests for breast lesion abnormalities at home, utilizing artificial intelligence for accurate detection. This technology addresses the challenge of early breast cancer diagnosis by providing a non-intrusive, affordable, and efficient screening method.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for breast cancer screening often involve clinic visits, specialized equipment, and trained personnel, which can be inconvenient, costly, and inaccessible for many women. This can lead to delayed detection and treatment of breast abnormalities. Many breast tumors are found by women themselves, highlighting the need for accessible self-screening tools.
Solution
Feminai offers a smart, wearable, disposable patch that allows women to perform self-tests for breast lesion abnormalities in the comfort of their homes. The patch is paired with a mobile application and leverages artificial intelligence to analyze the data collected and provide accurate detection of potential issues. This approach aims to make breast cancer screenings more accessible, affordable, and convenient, empowering women to take proactive control of their health. The non-intrusive nature of the patch promotes frequent and comfortable self-examinations.
Target Audience
The primary target audience is women who want a convenient, affordable, and accessible method for self-screening for breast abnormalities.
Features
- Smart, wearable, disposable patch for at-home breast lesion abnormality detection
- AI-powered analysis of data collected by the patch
- Mobile application for guiding self-testing and displaying results
- Non-intrusive and comfortable design for frequent use
- Remote self-testing capabilities